“SETsquared enabled GenomeKey to access a thriving ecosystem of startups and investors in the Bristol area.
We learnt from the journey of other SETsquared founders and their companies, and the shared wisdom helped us avoid many of the dangers all startups face.”
Provides Sepsis diagnosis in hours, rather than days, using cutting-edge machine learning and DNA Sequencing.
Top 3 achievements:
Antibiotic resistance is considered the “other global warming” threatening the lives and well-being of everyone on the planet. GenomeKey’s technology is unique in being able to offer a rapid, accurate, and low-cost diagnosis direct from blood, which will save lives, save money, and save our antibiotics for the future
GenomeKey has raised £2.6m in non-dilutive funding, £500,000 from Bristol investors, and £1m from Innovate UK
Winner of the prestigious SETsquared ‘Success of the Month’ award.